NGC Update Service: October 26, 2015 ► U.S. Food and Drug Administration (FDA) Advisory

NGC Update Service: October 26, 2015

U.S. Food and Drug Administration (FDA) Advisory

• October 22, 2015: Kayexalate (sodium polystyrene sulfonate): FDA is requiring the Kayexalate manufacturer to conduct studies to investigate Kayexalate's potential to bind to other medications administered by mouth – drug interactions that could affect how well the other medications work.

NGC Update Service: October 26, 2015